THE EFFECT OF REMOXIPRIDE, A NOVEL DOPAMINE-D2 RECEPTOR BLOCKER, IN CHRONIC-SCHIZOPHRENIA, AN OPEN STUDY

被引：0
|
作者：
LINDSTROM, LH
BESEV, G
STENING, G
NILSSON, MI
WIDERLOV, E
机构：
[1] UNIV UPPSALA,PSYCHIAT RES CTR,S-75105 UPPSALA,SWEDEN
[2] ASTRA LAKEMEDEL,RES CLIN,SODERTALJE,SWEDEN
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 1987年 / 32卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：529 / 530
页数：2
相关论文
共 50 条
  • [1] AN OPEN STUDY OF REMOXIPRIDE, A NEW NEUROLEPTIC, IN CHRONIC-SCHIZOPHRENIA
    DEVANEY, N
    KING, DJ
    COOPER, SJ
    MITCHELL, MJ
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 835 - 835
  • [2] REMOXIPRIDE, A SELECTIVE DOPAMINE-D2 RECEPTOR ANTAGONIST, IN TARDIVE-DYSKINESIA
    ANDERSSON, U
    HAGGSTROM, JE
    NILSSON, MI
    WIDERLOV, E
    [J]. PSYCHOPHARMACOLOGY, 1988, 94 (02) : 167 - 171
  • [3] B-HT 920, A DOPAMINE-D2 AGONIST, IN THE TREATMENT OF NEGATIVE SYMPTOMS OF CHRONIC-SCHIZOPHRENIA
    OHMORI, T
    KOYAMA, T
    INOUE, T
    MATSUBARA, S
    YAMASHITA, I
    [J]. BIOLOGICAL PSYCHIATRY, 1993, 33 (10) : 687 - 693
  • [4] PET imaging of dopamine-D2 receptor internalization in schizophrenia
    J J Weinstein
    E van de Giessen
    R J Rosengard
    X Xu
    N Ojeil
    G Brucato
    R B Gil
    L S Kegeles
    M Laruelle
    M Slifstein
    A Abi-Dargham
    [J]. Molecular Psychiatry, 2018, 23 : 1506 - 1511
  • [5] PET imaging of dopamine-D2 receptor internalization in schizophrenia
    Weinstein, J. J.
    van de Giessen, E.
    Rosengard, R. J.
    Xu, X.
    Ojeil, N.
    Brucato, G.
    Gil, R. B.
    Kegeles, L. S.
    Laruelle, M.
    Slifstein, M.
    Abi-Dargham, A.
    [J]. MOLECULAR PSYCHIATRY, 2018, 23 (06) : 1506 - 1511
  • [6] THE NEW SELECTIVE DOPAMINE-D2 ANTAGONIST, REMOXIPRIDE, IN THE TREATMENT OF ACUTE SCHIZOPHRENIA - A CANADIAN MULTICENTER TRIAL
    AWAD, AG
    LAPIERRE, YD
    NAIR, NPV
    BEAUDRY, P
    SAXENA, B
    CHOUINARD, G
    MCCLURE, J
    JONES, B
    BAKISH, D
    ANCILL, R
    MAX, P
    SANDOR, P
    MANCHANDA, R
    [J]. SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 311 - 312
  • [7] SELECTIVE DOPAMINE-D2 ANTAGONIST AND PROLACTIN RESPONSE IN ACUTE SCHIZOPHRENIA - RESULTS FROM REMOXIPRIDE STUDIES
    AWAD, AG
    LAPIERRE, YD
    JOSTELL, KG
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1990, 14 (05): : 769 - 777
  • [8] PARTIAL BRAIN DOPAMINE-D2 RECEPTOR AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA
    COWARD, D
    DIXON, K
    ENZ, A
    SHEARMAN, G
    URWYLER, S
    WHITE, T
    KAROBATH, M
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (03) : 393 - 397
  • [9] BINDING CHARACTERISTICS OF REMOXIPRIDE AND ITS METABOLITES TO DOPAMINE-D2 AND DOPAMINE-D3 RECEPTORS
    MOHELL, N
    SALLEMARK, M
    ROSQVIST, S
    MALMBERG, A
    HOGBERG, T
    JACKSON, DM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (01) : 121 - 125
  • [10] STEREOELECTRONIC STUDY OF ZETIDOLINE, A DOPAMINE-D2 RECEPTOR ANTAGONIST
    COLLIN, S
    EVRARD, G
    VERCAUTEREN, DP
    DURANT, F
    CARRUPT, PA
    VANDEWATERBEEMD, H
    TESTA, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) : 38 - 42
12345